Fall is upon us. In other words, it’s virus time. Kids are back in school – a great petri dish for cooking up viruses to take ...

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older adults also need protection against another risky winter virus, RSV. Yes, you ...

What to know about the XEC Covid variant, which is now in the U.S. Is it more contagious and do the updated vaccines work against it?

Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...

Updated rapid tests are expected to be able to detect newer variants just as a new COVID variant arrives in Minnesota.

Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...

Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines.

The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years? Does this sound a bit ...